ArticleAngewandte Chemie (International ed. in English)2025
A Phenazine-Based Two-Dimensional Covalent Organic Framework for Photochemical CO
Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bisphenazine-Based Porous Aromatic Frameworks for Photocatalytic and Electrocatalytic Oxygen Activation.ACS applied nano materials · 2026Article
- Isoreticular Tuning of Conductive Metal-Organic Framework Nanocrystals for the Rapid Detection and Differentiation of Toxic Gases.ACS nano · 2026Article
- From Binary to Ternary Hydrogen-Bonded Solids with Anisotropic Thermal Expansion.ACS materials Au · 2026Article
- A Phenazine-Based Two-Dimensional Covalent Organic Framework for Photochemical COAngewandte Chemie (International ed. in English) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The reduction of carbon dioxide (CO₂) into valuable products will contribute to sustainable carbon use. Here we report the photocatalytic reduction of CO₂ to carbon monoxide, formate, and oxalate ions using a redox-active phenazine-based 2D covalent organic framework (Phen-COF) and its phenazine monomer. Under similar irradiation conditions, Phen-COF produced 2.9 times more CO, 11 times more formate, and 13 times more oxalate compared to equimolar amounts of the monomeric phenazine, demonstrating that the COF architecture enhances catalytic performance (TOF
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.